SCHEMBL4092959

SCHEMBL4092959

Nc1ccc(Oc2ccc(Oc3cccc(Oc4ccc(Oc5ccc(N)cc5)cc4)c3)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 1.00
▸ MAPT P10636 5/20 1.00
▸ MEN1 O00255 4/20 1.00
▸ KMT2A Q03164 4/20 1.00
▸ SMN1; SMN2 Q16637 3/20 1.00
▸ MITF O75030 1/20 1.00
▸ GAA P10253 1/20 1.00
▸ GFER P55789 1/20 1.00
▸ NLRP1 Q9C000 1/20 1.00
▸ NOD2 Q9HC29 1/20 1.00
▸ MAOA P21397 2/20 0.73
▸ TDP1 Q9NUW8 2/20 0.70
▸ CYP3A4 P08684 1/20 0.70
▸ TSHR P16473 1/20 0.70
▸ NPC1 O15118 2/20 0.69
▸ RAB9A P51151 2/20 0.69
▸ NLRP3 Q96P20 1/20 0.69
▸ MAOB P27338 2/20 0.64
▸ TEAD4 Q15561 1/20 0.56
▸ FURIN P09958 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964017 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6290330 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6290623 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1270594 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6289307 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1271678 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL63594 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL562469 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL22289568 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL29948036 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7026018-A — — None — — JP disclosed
US-12378184-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2025-08-05 — — US disclosed
US-20240294813-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-09-05 — — US disclosed
US-20240294754-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-09-05 — — US disclosed
US-20240286341-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-08-29 — — US disclosed
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2024-06-25 — — US disclosed
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2024-06-25 — — US disclosed
US-20240199531-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-06-20 — — US disclosed
US-20240124652-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-04-18 — — US disclosed
US-20240109837-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE 2024-04-04 — — US disclosed
CN-109937380-B Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学株式会社 2022-04-19 — — CN disclosed
US-9459494-B2 Liquid crystal aligning agent and liquid crystal display device employing it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-04 — — US disclosed
US-20140023798-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING IT NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2014-01-23 — — US disclosed
US-20090220707-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING IT NISSAN CHEMICAL INDUSTRIES LIMITED (JP) 2009-09-03 — — US disclosed
US-20060142538-A1 Liquid crystal orientating agent and liquid crystal display element using it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2006-06-29 — — US disclosed
JP-H0726018-A AROMATIC DIAMINE, AND POLYIMIDE AND ITS PRODUCTION AND USE MITSUI TOATSU CHEM INC 1995-01-27 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199531-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM TPR, AS3MT, ASF1A ALDH1A1 2790/4885MAPT 231/4885MEN1 4391/4885
US-20240109837-A1 ALL-AROMATIC LIQUID-CRYSTALLINE HOMO-POLYIMIDES WITH AROMATIC ENDGROUPS AND CROSSLINKED PRODUCTS THEREFROM TPR, AS3MT, ASF1A ALDH1A1 2790/4885MAPT 231/4885MEN1 4391/4885
US-12017972-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom TPR, AS3MT, ASF1A ALDH1A1 2790/4885MAPT 231/4885MEN1 4391/4885
US-12378184-B2 All-aromatic liquid-crystalline homo-polyimides with aromatic endgroups and crosslinked products therefrom TPR, AS3MT, ASF1A ALDH1A1 2790/4885MAPT 231/4885MEN1 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback